Clinical trial of insoles for pain at the front of the knee

ISRCTN	ISRCTN84641129
DOI	https://doi.org/10.1186/ISRCTN84641129
Secondary identifying numbers	CT223

Submission date: 23/04/2008
Registration date: 31/07/2008
Last edited: 06/05/2016

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Musculoskeletal Diseases

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr Christopher Nester
Scientific

Director
Centre for Rehabilitation & Human Performance Research
Brian Blatchford Building
University of Salford
Salford
M6 6PU
United Kingdom

Phone	+44 (0)161 295 2275
Email	c.j.nester@salford.ac.uk

Study information

Study design	Randomised subject-blinded single-centre trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Not specified
Study type	Treatment
Participant information sheet	Not available in web format, please use the contact details below to request a patient information sheet
Scientific title	A randomised controlled trial to evaluate the effectiveness of insoles to treat anterior knee (patella femoral) pain
Study acronym	KP Trial
Study hypothesis	Knee pain remains a significant burden to a large proportion of the population. It has a multifactorial etiology and diagnosis is often non specific. Anterior knee pain (patellofemoral pain syndrome) has been described as the most prevalent disorder of the knee. The cause of the condition is not clearly understood and the cause of pain may not be the same for each person. Hence a variety of treatment regimes (devices) are employed for the treatment of the condition. Citizens are likely to seek their own approaches to managing knee pain prior whilst waiting for, or instead of, seeking advice and remedy from the health services. This trial will seek to evaluate the effectiveness of an in shoe type of orthosis in the management of anterior knee pain. Hypothesis: a functional insole will produce greater improvements in knee pain compared to a sham control group.
Ethics approval(s)	Ethics Committee, University of Salford, 12/03/2008, ref: 07/054
Condition	Anterior knee pain
Intervention	The participants will be randomly allocated to the following two arms: 1. Arm 1: Orthaheel® regular. This is a 3/4 length insole with arch shape. It is inserted into shoes and worn daily for 12 months 2. Arm 2: Sham control insole. This is a full length 3 mm deep soft flat insole. It is inserted into shoes and worn daily for 12 months
Intervention type	Other
Primary outcome measure	1. Knee pain 2. Knee function The outcomes above will be measured using the following at 4 weeks: a. VAS (scores 0-10) b. The Kujala Anterior knee pain questionnaire
Secondary outcome measures	1. Use of insoles (in time) 2. Knee pain at 3, 6 and 12 months (see primary outcome measures for methods of measurement) 3. Knee function at 3, 6 and 12 months (see primary outcome measures for methods of measurement)
Overall study start date	28/03/2008
Overall study end date	31/07/2009

Eligibility

Participant type(s)	Patient
Age group	Adult
Lower age limit	18 Years
Sex	Both
Target number of participants	100
Participant inclusion criteria	1. Male or female participants between the ages of 18 and 65 years old 2. Participants with self-reported anterior knee pain (pain at the front of the knee) with a minimum of 4 weeks duration 3. Participants with self-reported anterior knee pain who score at least 40 mm on a 100 mm visual analogue scale (VAS) for pain 4. Participants with self-reported anterior knee pain in the 2 days prior to recruitment 5. Participants who agree to wear the insoles provided for at least 4 hours each day and complete diary cards and postal questionnaire as required 6. Participants who give written informed consent
Participant exclusion criteria	1. Patients must not report any acute injury to the knee at the onset of their anterior knee pain 2. Patients must not report posterior or medial/lateral knee pain or any secondary pain elsewhere in lower limb joints since the onset of anterior knee pain 3. Patients must not have any significant diagnosed musculo-skeletal disease, such as rheumatoid arthritis, diabetes or osteoarthritis of the knee or deterioration dysfunction of associated structures of the knee e.g., cartilage or any other condition associated with sensory and motor dysfunction 4. Patients must not have received or self administered treatment for the knee pain in the previous 4 weeks 5. Patients who are pregnant or breast-feeding 6. Patients who have received or self-administered treatment for the knee pain in the previous 4 weeks 7. Patients who have received corticosteroid injection therapy in the knee in the previous 3 months 8. Patients that were previously in this study 9. Patients that were in another study within the last 3 months
Recruitment start date	28/03/2008
Recruitment end date	31/07/2009

Locations

Countries of recruitment

England
United Kingdom

Study participating centre

Director

Salford
M6 6PU
United Kingdom

Sponsor information

SSL International (UK)
Industry

SSL International Plc
Venus Building
1 Old Park Lane
Trafford
Urmston
Manchester
M41 7HA
United Kingdom

Website	http://www.ssl-international.com
"ROR"	https://ror.org/01g87hr29

Funders

Funder type

Industry

SSL International (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Editorial Notes

06/05/2016: No publications found, verifying study status with principal investigator.